Psychosocial Factors Related to Musculoskeletal Disorders in Academicians (MSDs)

April 27, 2026 updated by: ERDİ KAYABINAR, University of Yalova

The Investigation of the Effects of Academic Stress and Burnout on Musculoskeletal Disorders in Academicians

the prevalence of occupational stress and burnout is very high among academicians. Previous studies examining MSDs in academicians have focused more on physical factors such as physical activity levels and ergonomics, while interest in psychosocial factors has been limited. To our knowledge, there is no study in the literature that evaluates both MSDs, work stress, and burnout in academicians. Therefore, our study aims to investigate the relationship between MSDs and academic stress, burnout, and work-life balance among academicians.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The study aims to investigate psychosocial factors such as academic stress and burnout, which are thought to influence musculoskeletal disorders among academics. As part of the research, data will be collected through questionnaires from volunteer academics at a selected university who have at least six months of teaching experience at the institution. The questionnaire will gather information on musculoskeletal pain, demographic characteristics, stress levels, burnout levels, and work-life balance. After entering the data into the SPSS software, statistical analysis will be conducted. Categorical variables will be presented as numbers (percentages), and numerical variables will be reported as means and standard deviations. To assess correlations, Spearman or Pearson correlation tests and regression analyses will be used. The Chi-square test will be used to compare categorical variables between male and female academics, while the independent samples t-test will be applied for numerical variables if normality is assumed; otherwise, the Mann-Whitney U test will be used. The Shapiro-Wilk test will be conducted to assess the normality of the data. A significance level of p<0.005 will be considered statistically significant.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
99

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Yalova
      • Yalova, Yalova, Turkey (Türkiye), 77100
        • University of Yalova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Academicians who worked as academic staff at Yalova University for the past six months

Description

Inclusion Criteria:

  • volunteering to participate,
  • having worked as academic staff at Yalova University for the past six months,
  • being able to understand and speak Turkish

Exclusion Criteria:

  • who wished to withdraw from the study,
  • those with a history of fracture or soft tissue injury in any body region within the past 12 months,
  • congenital spinal disorders, scoliosis, rheumatoid diseases, cancer, surgery, chronic internal organ pain, long-term use of analgesic or psychiatric medications, - those working in departments without students

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Academicians
Academicans with muscoloskeletal disorders

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The Extended Nordic Musculoskeletal Questionnaire
Time Frame: All participants will be assessed only once on Day 1.
Dawson and colleagues developed an extended version of the Nordic Musculoskeletal Questionnaire to obtain more detailed data on the prevalence and impact of musculoskeletal disorders. It includes general questions about the history of problems in nine body regions, such as the neck, upper back, shoulders, elbows, hands/arms, lower back, hips, knees, and feet/ankles. The questionnaire was provided along with a body diagram to help participants indicate areas of pain or discomfort. The response options are limited to "yes" and "no." A Turkish cultural adaptation and validity study of the questionnaire has been conducted.
All participants will be assessed only once on Day 1.
University Academic Staff Work Stress Scale
Time Frame: All participants will be assessed only once on Day 1.
University Academic Staff Work Stress Scale, developed by Balcı in 1992 and validated for reliability and validity, was used. The scale contains 24 items. The total scale score ranges from 0 to 120, with higher scores indicating lower job satisfaction. The questionnaire has high validity and reliability.
All participants will be assessed only once on Day 1.
The Maslach Burnout Inventory
Time Frame: All participants will be assessed only once on Day 1.
The Maslach Burnout Inventory was developed by Maslach and Jackson in 1981. The inventory has also been validated and tested for reliability for use in Turkish among academicians. The inventory consists of 22 items and assesses burnout across three subscales: emotional exhaustion, depersonalization, and personal accomplishment. The emotional exhaustion subscale includes nine items related to fatigue, boredom, and reduced emotional energy. The depersonalization subscale consists of five items concerning detached or impersonal behavior toward care and service recipients. The personal accomplishment subscale comprises eight items and reflects an individual's sense of competence and achievement. Items on the scale are rated on a Likert scale from 0 to 6. Separate scores were obtained for each of the three subscales. High scores on the emotional exhaustion or depersonalization subscales, or low scores on the personal accomplishment subscale, indicate a high level of burnout.
All participants will be assessed only once on Day 1.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Work-Life Balance Scale
Time Frame: All participants will be assessed only once on Day 1.
The scale, developed and tested for reliability by Taşdelen-Karçkay and Bakalım, evaluates the balance between work and life. It consists of 8 items rated on a 7-point Likert scale, with each item scored from "Strongly Disagree -1-" to "Strongly Agree -7-." Low scores indicate a disruption in work-life balance.
All participants will be assessed only once on Day 1.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Yalova

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Erdi KAYABINAR, PhD, University of Yalova

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 2, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 20, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 20, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 28, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 28, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 11, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 4, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 27, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2024/292

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The researchers do not plan to share the data due to concerns about data confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings